CN113812613A - Uric acid resistant functional food and preparation process thereof - Google Patents
Uric acid resistant functional food and preparation process thereof Download PDFInfo
- Publication number
- CN113812613A CN113812613A CN202110232538.5A CN202110232538A CN113812613A CN 113812613 A CN113812613 A CN 113812613A CN 202110232538 A CN202110232538 A CN 202110232538A CN 113812613 A CN113812613 A CN 113812613A
- Authority
- CN
- China
- Prior art keywords
- parts
- functional food
- uric acid
- raw materials
- acid functional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940116269 uric acid Drugs 0.000 title claims abstract description 31
- 235000013376 functional food Nutrition 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title abstract description 22
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 38
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 29
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 29
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 29
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 29
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 29
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 29
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 29
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 29
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 29
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 29
- 241001523681 Dendrobium Species 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 25
- 241000931705 Cicada Species 0.000 claims abstract description 23
- 241001625026 Cordyceps cicadae Species 0.000 claims abstract description 22
- 241000233866 Fungi Species 0.000 claims abstract description 17
- 239000000052 vinegar Substances 0.000 claims abstract description 13
- 235000021419 vinegar Nutrition 0.000 claims abstract description 13
- 239000008187 granular material Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 22
- 244000046146 Pueraria lobata Species 0.000 claims description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 19
- 244000111489 Gardenia augusta Species 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 13
- 238000012545 processing Methods 0.000 claims description 13
- 238000010298 pulverizing process Methods 0.000 claims description 13
- 238000002791 soaking Methods 0.000 claims description 12
- 244000061458 Solanum melongena Species 0.000 claims description 11
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 10
- 235000002597 Solanum melongena Nutrition 0.000 claims description 10
- 244000153885 Appio Species 0.000 claims description 9
- 235000010591 Appio Nutrition 0.000 claims description 9
- 244000042430 Rhodiola rosea Species 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 9
- 235000003713 Rhodiola rosea Nutrition 0.000 claims description 8
- 240000009022 Smilax rotundifolia Species 0.000 claims description 8
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 8
- 235000006533 astragalus Nutrition 0.000 claims description 8
- 235000013361 beverage Nutrition 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 244000144725 Amygdalus communis Species 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 244000298479 Cichorium intybus Species 0.000 claims description 5
- 235000003893 Prunus dulcis var amara Nutrition 0.000 claims description 5
- 241001061264 Astragalus Species 0.000 claims description 4
- 240000004638 Dendrobium nobile Species 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 210000004233 talus Anatomy 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 2
- 241000205585 Aquilegia canadensis Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 43
- 241001092040 Crataegus Species 0.000 abstract description 28
- 239000003814 drug Substances 0.000 abstract description 23
- 201000005569 Gout Diseases 0.000 abstract description 19
- 238000002560 therapeutic procedure Methods 0.000 abstract description 13
- 231100000331 toxic Toxicity 0.000 abstract description 12
- 230000002588 toxic effect Effects 0.000 abstract description 12
- 230000006870 function Effects 0.000 abstract description 11
- 235000005911 diet Nutrition 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000029142 excretion Effects 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 230000000378 dietary effect Effects 0.000 abstract description 3
- 208000035240 Disease Resistance Diseases 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 241000723343 Cichorium Species 0.000 description 27
- 240000001972 Gardenia jasminoides Species 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 235000013305 food Nutrition 0.000 description 12
- 241001122767 Theaceae Species 0.000 description 10
- 235000013616 tea Nutrition 0.000 description 10
- 241000357408 Ophiocordyceps sobolifera Species 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 229940126673 western medicines Drugs 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 241001570521 Lonicera periclymenum Species 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 235000009827 Prunus armeniaca Nutrition 0.000 description 5
- 244000018633 Prunus armeniaca Species 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 241000045403 Astragalus propinquus Species 0.000 description 4
- 241001164374 Calyx Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000190633 Cordyceps Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 229940107666 astragalus root Drugs 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 244000167230 Lonicera japonica Species 0.000 description 2
- 235000017617 Lonicera japonica Nutrition 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 241000220222 Rosaceae Species 0.000 description 2
- 244000111146 Sonchus arvensis Species 0.000 description 2
- 235000006731 Sonchus arvensis Nutrition 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000015091 medicinal tea Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 229960003081 probenecid Drugs 0.000 description 2
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 235000015577 Armeniaca sibirica Nutrition 0.000 description 1
- 244000141006 Armeniaca sibirica Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241001415440 Bufo gargarizans Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 235000014493 Crataegus Nutrition 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 241001466452 Laminariaceae Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241000244274 Pternopetalum Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241001165494 Rhodiola Species 0.000 description 1
- 241000997135 Rhodiola crenulata Species 0.000 description 1
- 235000003524 Rhodiola rosea subsp rosea Nutrition 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241000015177 Saccharina japonica Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241001404789 Smilax glabra Species 0.000 description 1
- 206010041290 Soft tissue inflammation Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 description 1
- 241001123264 Zosteraceae Species 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002529 benzbromarone Drugs 0.000 description 1
- WHQCHUCQKNIQEC-UHFFFAOYSA-N benzbromarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 WHQCHUCQKNIQEC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000850 chronic interstitial nephritis Toxicity 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229960005101 febuxostat Drugs 0.000 description 1
- BQSJTQLCZDPROO-UHFFFAOYSA-N febuxostat Chemical compound C1=C(C#N)C(OCC(C)C)=CC=C1C1=NC(C)=C(C(O)=O)S1 BQSJTQLCZDPROO-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to a functional food and a preparation method thereof, in particular to an anti-uric acid functional food and a preparation process thereof. The raw materials comprise hawthorn, dendrobium and cicada fungus. The preparation method comprises the following steps: the cordyceps cicadae is soaked in vinegar, dried, mixed with the dendrobium and the hawthorn, crushed, treated for 4 to 8 seconds under the pressure of 0.18 to 0.25MPa of steam at the temperature of 120 ℃, fermented for 20 to 24 hours at the temperature of 25 to 30 ℃, ground into fine powder by a low-temperature wall breaking machine, and prepared into drinks or tablets or instant granules. The beneficial effects are that: the prepared functional food can enhance the function of excretion of uric acid of a human body, has quick effect, no toxic or side effect, can quickly relieve and even eliminate gout symptoms, can provide various nutrient components for the human body, improve the functions of liver and kidney, improve the disease resistance of the human body, has the effects of prevention, rehabilitation and auxiliary treatment for patients with high uric acid content and gout, has good synergistic effect on various existing medicines, has soft taste, convenient eating and low cost, and is expected to become a dietary therapy product favored by people with high uric acid content and patients with gout.
Description
Technical Field
The invention relates to a functional food and a preparation method thereof, in particular to an anti-uric acid functional food and a preparation process thereof.
Background
Gout is an inflammatory disease induced by mono-natriuretic urate crystals, and hyperuricemia can be caused by long-term purine metabolism activity, purine intake excess or uric acid excretion disorder. Long-term hyperuricemia can cause deposition of urate crystals in joints and surrounding soft tissues, and further repeated acute joint and soft tissue inflammation, tophus deposition, chronic arthritis and joint damage occur. Hyperuricemia also affects the kidney, causing chronic interstitial nephritis and urate calculi formation. The early active uric acid lowering treatment of gout patients can delay or prevent organ damage. At present, gout treatment mainly comprises drug therapy and dietary therapy, and the drugs comprise western medicines and traditional Chinese medicines. Western medicines such as non-steroidal anti-inflammatory drug, colchicine, and glucocorticoid used in acute stage are provided. Allopurinol, febuxostat, benzbromarone, probenecid and other uric acid reducing medicines are adopted in the chronic stage. Western medicines have quick response but strong toxic and side effects and are not suitable for long-term use. The traditional Chinese medicine has various varieties, but the traditional Chinese medicine takes effect too slowly, hardly has effect on gout in the acute attack stage, is poor in taste and painful to take in most of the gout, and also has some toxic and side effects. The food therapy adopts the materials which are approved by the state and have homology of medicine and food, and has no toxic and side effect. Particularly, some medicinal tea drinks, such as famous chicory gardenia tea and the like, can supplement water and promote urination, promote excretion of uric acid and have good mouthfeel, so the medicinal tea drink is suitable for long-term administration. However, the existing food therapy has the problem of slow effect, even slower than traditional Chinese medicine, thereby limiting the popularization of food therapy. If the obvious effect process of food therapy can be accelerated, the food therapy becomes a main means for resisting gout, thereby bringing good news to gout patients and even the whole society.
Disclosure of Invention
The invention aims to provide a dietotherapy product which has good treatment or auxiliary treatment effect on gout, quick response, convenient use, low cost and no toxic or side effect, and a preparation method thereof.
The above purpose is realized by the following technical scheme: provides a functional food for resisting uric acid, which is characterized in that: the functional food comprises fructus crataegi, herba Dendrobii, and Cordyceps cicadae.
The functional food comprises the following raw materials in parts by weight: 1-3 parts of hawthorn, 2-4 parts of dendrobium nobile and 1-2 parts of cicada fungus.
The preparation method of the functional food comprises the following steps: the cordyceps cicadae is soaked in mature vinegar for 20-24 hours, dried, mixed with dendrobium and hawthorn and crushed into coarse powder, treated for 4-8 seconds under the pressure of 0.18-0.25 MPa of steam at 120 ℃, added with distilled water and yeast, mixed uniformly into a wet residue shape, fermented for 20-24 hours at 25-30 ℃, ground into fine powder with the granularity of more than 200 meshes by using a low-temperature wall breaking machine, and prepared into drinks or tablets or instant granules.
The Cordyceps cicadae is replaced by herba Zosterae Marinae and radix astragali.
2-4 parts of chicory, 2-4 parts of gardenia jasminoides and 1-3 parts of kudzu root are added into the raw materials.
The raw materials are added with 2-4 parts of chicory, 2-4 parts of gardenia jasminoides, 1-3 parts of kudzu root and 1-3 parts of glabrous greenbrier rhizome.
The raw materials are added with 2-4 parts of chicory, 2-4 parts of gardenia jasminoides, 1-3 parts of kudzu root and 1-4 parts of rhodiola rosea.
3-7 parts of eggplant stalk pedicel, 3-5 parts of celery root, 2-4 parts of bitter almond and 1-3 parts of honeysuckle are added into the raw materials.
The preparation method of the functional food comprises the following steps: soaking Cordyceps cicadae in old vinegar for 20-24 hr, drying, mixing with herba Dendrobii and fructus crataegi, pulverizing into coarse powder, treating with steam at 120 deg.C under 0.18-0.25 MPa for 4-8 s, adding distilled water and yeast, mixing to obtain wet residue, fermenting at 25-30 deg.C for 20-24 hr, and grinding into fine powder of 200 meshes or more with low temperature wall breaking machine; pulverizing other raw materials with low temperature wall breaking machine, adding water to submerge the raw materials, heating to boil, stopping heating, naturally cooling to 70-75 deg.C, maintaining the water evaporation to wet residue state, soaking in 95% ethanol for 1-1.5 hr, adding ultrasonic vibration, recovering ethanol, mixing the rest materials with Cordyceps cicadae, herba Dendrobii, and fructus crataegi, stirring, and processing with microwave processor to obtain beverage or tablet or instant granule.
The invention has the beneficial effects that: the prepared functional food can enhance the function of human body for excretion of uric acid, has quick effect, no toxic or side effect, can quickly relieve and even eliminate gout symptoms, can provide various nutrient components for human bodies, improves the functions of liver and kidney and microcirculation level, greatly improves the disease resistance of human bodies, has the effects of prevention, rehabilitation and auxiliary treatment for patients with high uric acid and gout, has good synergistic effect on various existing medicines, has soft taste, is convenient to eat and low in cost, and can be expected to become a preferred diet therapy product for people with high uric acid and patients with gout.
Detailed Description
The first embodiment: the functional food with the effect of preventing and treating gout is provided, and is characterized in that: the functional food comprises fructus crataegi, herba Dendrobii, and Cordyceps cicadae. The weight ratio is as follows: 1-3 parts of hawthorn, 2-4 parts of dendrobium nobile and 1-2 parts of cicada fungus. Preferably 3 parts of hawthorn, 3 parts of dendrobium and 2 parts of cicada fungus. Preparing the beverage by adopting a conventional processing mode, such as: pulverizing, decocting in water, concentrating, and making into various dosage forms. The administration method is tea drink. The medicine is taken 3-5 times a day after being infused into 500ml of liquid 15-20 g for an adult each time.
Fructus crataegi is dried mature fruit of Crataegus Pinnatifida Bge of Crataegus of Rosaceae. Has effects of resolving food stagnation, activating qi-flowing and removing blood stasis. It can be used for treating food stagnation, dysentery, abdominal pain, hernia pain, stagnation of blood, chest pain, dysmenorrhea, etc.
The stem and leaf of Dendrobium nobile (Brandrebium nobile) in Orchidaceae has effects of resisting oxidation, lowering blood sugar, delaying aging, dilating blood vessel, lowering blood viscosity, reducing blood lipid, and preventing thrombosis.
Cicada fungus, english name: vegetable cicada, also called Jinchan grass, is also called silkworm chrysalis, cicada flower, worm flower, cicada shell, flower and cicada grass. The root of the cicada fungus is the larva of the cicada pupa or the cicada, and the fungus grows from the head of a single or 2-3 cicada larvae. Research shows that the cordyceps cicadae has multiple functions of improving immunity, resisting fatigue, protecting kidney, improving sleep, resisting tumor, protecting liver, resisting radiation, improving eyesight and the like. The artificially cultured Cordyceps sobolifera contains mannitol, polysaccharide, amino acids, cordycepin and adenosine, and is similar to natural Cordyceps. Therefore, the cordyceps sobolifera can be used as a substitute of cordyceps sinensis to achieve the purpose of nourishing and preserving health. However, the artificially cultured cordyceps sobolifera does not contain toxic heavy metals such as arsenic, mercury, lead and the like, so that the safety of the cordyceps sobolifera is higher than that of natural cordyceps sinensis.
In the formula, the raw materials comprise hawthorn, dendrobium and cicada fungus, and the inclusion has two meanings according to the specification of national languages. One is "only these three materials". The second is "other raw materials", which mainly refers to the raw materials involved in the following examples.
The research process of the formula is briefly described as follows: in the clinic of gout, the treatment of gout mainly comprises drug treatment and food therapy. The medicine comprises western medicine and Chinese medicine. Western medicines have quick response, can relieve pain in 1 to 2 days, but have strong toxic and side effects, are not suitable for long-term use and cannot radically cure the diseases. The traditional Chinese medicine has slow effect, poor taste and toxic and side effects, and can not be taken for a long time. The food therapy has good taste, no toxic or side effect, is beneficial to the body, can be taken for a long time, but also has the defect of slow effect. Therefore, it is desirable to find a fast acting food therapy product. In 2013-2015, the effect taking time of the formula is found to be obviously faster than that of a similar diet therapy formula in clinic, and the formula is slower than that of western medicines, but still has important significance and arouses attention of people. Therefore, the medical records of the past years are analyzed and studied.
The data sorting method comprises the following steps: 90 male cases (because gout is mostly male), are divided into three groups, namely an experimental group, a control group 1 and a control group 2, and each group has 30 cases. The experimental group adopts the medicinal granules prepared by the formula, and the control group 1 adopts a commercially available product, namely the chicory and gardenia tea, and the formula comprises the chicory, the mulberry leaf, the kudzu root, the gardenia, the lily and the cassia seed. The control group 2 mainly used the western medicine probenecid. According to the current standard, the uric acid value of a male adult is 300-350 mu mol/L which is a normal value, the uric acid value of the male adult is spontaneously developed when the blood uric acid value is above 420 mu mol/L, and the blood uric acid value of a clinical patient is about 500 mu mol/L mostly. The time from the start of administration to the time at which the pain was reduced and the uric acid level began to decline is shown in the table. The relief time shown in the table is a time until the uric acid level becomes stable at 420. mu. mol/L or less and pain substantially disappears after administration.
The statistical results show that: the western medicine has the shortest effective time, and the chicory gardenia tea has the longest effect in the formula of the group. Although the effective time of the prescription is longer than that of western medicines, the prescription is not regarded as important because of poor radical cure effect and toxic and side effects. Although the relieving time of the formula is longer than that of chicory gardenia tea, the gout is attacked more quickly, and the pain is quickly relieved. Therefore, the formula has important clinical significance.
The second embodiment: in order to further shorten the effective time of the formula, various explorations are carried out on the manufacturing process, and various process routes which are feasible in ratio are screened. The example only introduces a processing technology with better effect: the cordyceps cicadae is soaked in mature vinegar for 20-24 hours, dried, mixed with dendrobium and hawthorn and crushed into coarse powder, treated for 4-8 seconds under the pressure of 0.18-0.25 MPa of steam at 120 ℃, added with distilled water and yeast, mixed uniformly into a wet residue shape, fermented for 20-24 hours at 25-30 ℃, ground into fine powder with the granularity of more than 200 meshes by using a low-temperature wall breaking machine, and prepared into drinks or tablets or instant granules.
The technical key point of the process is that the raw materials are fully refined on the premise of keeping the effective components as much as possible. The acetic acid treatment is very beneficial to the dissolution of the active ingredients of the cordyceps sinensis. The cordyceps, the dendrobium and the hawthorn are crushed together and mixed more uniformly. The high-temperature treatment is carried out quickly under the pressure of 2 atmospheres, so that the sterilization and activation can be realized, and the damage of high temperature to effective components can be prevented. Effective components can be further separated by fermentation, and cell walls are broken by low-temperature grinding, so that the effective components can be absorbed and utilized by human bodies more conveniently.
The processed product, compared to the first example, gave the following results:
the control group is a numerical value with reference to the formulation of the first example. The experimental group is the product made by the process of this example. Therefore, the effective time and the release time of the new processing technology are both greatly shortened, which indicates that the new processing technology is feasible.
Third embodiment: on the basis of the previous embodiment, the method is further improved, the main raw materials of the chicory and gardenia tea, namely chicory, gardenia jasminoides and kudzu vine root are added into the formula to form a new formula: 1-3 parts of hawthorn, 2-4 parts of dendrobium, 1-2 parts of cordyceps sobolifera, 2-4 parts of chicory, 2-4 parts of gardenia jasminoides ellis and 1-3 parts of kudzu root. Preferably 2 parts of hawthorn, 2 parts of dendrobium, 2 parts of cicada fungus, 3 parts of chicory, 2 parts of gardenia jasminoides and 2 parts of kudzu root.
Chicory (Cichorium intybus L.), also known as Sonchus arvensis, Carsini arvensis, Sonchus arvensis, Oldham, coffee radish, Compositae, Cichorium, perennial herbs. The aerial parts and roots of the plants can be used for medicine, the traditional Chinese medicines are chicory and chicory root respectively, and the traditional Chinese medicine has the effects of clearing away heat and toxic materials, inducing diuresis to reduce edema, invigorating stomach and the like. Is a plant used as both medicine and food, and has its leaf capable of being used as raw material, root containing inulin and aromatic substance, and capable of being used as substitute coffee for promoting digestive organ activity of human body.
Cape jasmine, another name: gardenia (with the scientific name of Gardenia jasminoides Ellis), also called Gardenia jasminoides, Gardenia jasminoides and bufo gargarizans are fruits of Gardenia jasminoides in the family of Rubiaceae, are traditional Chinese medicines, and have the effects of protecting liver, benefiting gallbladder, reducing blood pressure, tranquilizing, stopping bleeding, reducing swelling and the like. The traditional Chinese medicine is commonly used for treating icteric hepatitis, sprain and contusion, hypertension, diabetes and other diseases in clinic, and belongs to the first batch of medicinal and edible raw materials issued by the Ministry of health.
Kudzu root, english name: radix Puerarae, Lobed Kudzuvine Root. Is dried root of Pueraria lobata Ohwi of Leguminosae, commonly known as Pueraria lobata Ohwi. Sweet, pungent and cool. Has the functions of expelling pathogenic factors from muscles, allaying fever, promoting eruption, promoting the production of body fluid to quench thirst, invigorating yang and stopping diarrhea. It is commonly indicated for exterior syndrome with fever, stiffness and pain of neck and back, measles without adequate eruption, thirst due to fever, diabetes due to yin deficiency, dysentery due to heat-purging and diarrhea due to spleen deficiency.
The following processing technology is preferred: soaking Cordyceps cicadae in old vinegar for 20-24 hr, drying, mixing with herba Dendrobii and fructus crataegi, pulverizing into coarse powder, treating with steam at 120 deg.C under 0.18-0.25 MPa for 4-8 s, adding distilled water and yeast, mixing to obtain wet residue, fermenting at 25-30 deg.C for 20-24 hr, and grinding into fine powder of 200 meshes or more with low temperature wall breaking machine; pulverizing other raw materials by a low-temperature wall breaking machine, adding water to submerge the raw materials, heating to boil, stopping heating, naturally cooling to 70-75 ℃, maintaining the water evaporation to a wet residue state, and adding 95% ethanol for soaking for 1-1.5 hours. Mixing the above materials, and making into beverage, tablet or instant granule.
The above process is the preferred method of processing through a number of experiments. Wherein, the cicada fungus is soaked in mature vinegar to dissolve out the effective components, which is convenient for human body to absorb and utilize. The coarse powder of the dendrobium and the hawthorn is subjected to steam pressurization and rapid treatment, so that disinfection and sterilization can be realized, decomposition and modification of effective ingredients can be avoided, the effective ingredients can be fully separated out through fermentation, and the permeability of the dendrobium and the hawthorn can be greatly enhanced through low-temperature wall breaking. Other raw materials are also subjected to short-time high-heat treatment, active ingredients are preserved, and after the active ingredients are dissolved by ethanol, the ethanol is not required to be further extracted, and only the ethanol is recovered, so that the cost can be reduced, and the active ingredients are highly dissolved and are convenient to absorb and utilize.
The results of the statistical comparison are shown in the following table:
in the table, the experimental groups are the formulation data of this example; control 1 is the second example experimental group data; control 2 is data from the first example of chicory gardenia tea. Control group 3 western medicines are data of the first embodiment. As can be seen from the data, the effect-displaying time and the buffering time of the formula are further shortened.
The fourth embodiment: further improvements are made on the basis of the foregoing embodiments. The main raw materials of the chicory and gardenia tea, namely chicory, gardenia jasminoides, kudzu root and glabrous greenbrier rhizome are added into the formula to form a new formula: 1-3 parts of hawthorn, 2-4 parts of dendrobium, 1-2 parts of cordyceps sobolifera, 2-4 parts of chicory, 2-4 parts of gardenia jasminoides, 1-3 parts of radix puerariae and 1-3 parts of rhizoma smilacis glabrae. Preferably 2 parts of hawthorn, 2 parts of dendrobium, 2 parts of cicada fungus, 3 parts of chicory, 2 parts of gardenia jasminoides ellis, 2 parts of kudzu root and 1 part of glabrous greenbrier rhizome.
Glabrous greenbrier rhizome, english name: glabrous Greenbrier Rhizome is perennial evergreen climbing shrub of Liliaceae, and the part used as medicine is dried Rhizome. The functions are as follows: detoxify and dissipate nodulation, dispel wind and dredge collaterals, remove dampness and discharge turbidity. It can be used for treating syphilis, pharyngitis, carbuncle, cellulitis, malignant boil, scrofula, carcinoma, spasm and pain of muscles and bones, edema, stranguria with turbid urine, diarrhea, tinea pedis, eczema, scabies, and mercurial poisoning.
The following processing technology is preferred: soaking Cordyceps cicadae in old vinegar for 20-24 hr, drying, mixing with herba Dendrobii and fructus crataegi, pulverizing into coarse powder, treating with steam at 120 deg.C under 0.18-0.25 MPa for 4-8 s, adding distilled water and yeast, mixing to obtain wet residue, fermenting at 25-30 deg.C for 20-24 hr, and grinding into fine powder of 200 meshes or more with low temperature wall breaking machine; pulverizing other raw materials with low temperature wall breaking machine, adding water, heating to boil, stopping heating, naturally cooling to 70-75 deg.C, maintaining water evaporation to wet residue state, soaking in 95% ethanol for 1-1.5 hr, and making into beverage, tablet or instant granule.
The above process is the preferred method of processing through a number of experiments. Wherein, the cicada fungus is soaked in mature vinegar to dissolve out the effective components, which is convenient for human body to absorb and utilize. The coarse powder of the dendrobium and the hawthorn is subjected to steam pressurization and rapid treatment, so that disinfection and sterilization can be realized, decomposition and modification of effective ingredients can be avoided, the effective ingredients can be fully separated out through fermentation, and the permeability of the dendrobium and the hawthorn can be greatly enhanced through low-temperature wall breaking. Other raw materials are also subjected to short-time high-heat treatment, active ingredients are preserved, and after the active ingredients are dissolved by ethanol, the ethanol is not required to be further extracted, and only the ethanol is recovered, so that the cost can be reduced, and the active ingredients are highly dissolved and are convenient to absorb and utilize.
The results of the statistical comparison are shown in the following table:
in the table, the experimental groups are the formulation data of this example; control 1 is the second example experimental group data; the chicory gardenia tea and the western medicines are data of the first embodiment. It can be seen from the above data that the development time and the buffering time of the improved formulation and processing method are further shortened.
Fifth embodiment: on the basis of the third embodiment, the rhodiola root is used for replacing the glabrous greenbrier rhizome to form a new formula: 1-3 parts of hawthorn, 2-4 parts of dendrobium, 1-2 parts of cordyceps sobolifera, 2-4 parts of chicory, 2-4 parts of gardenia jasminoides, 1-3 parts of radix puerariae and 1-4 parts of rhodiola rosea. Preferably 2 parts of hawthorn, 2 parts of dendrobium, 2 parts of cicada fungus, 3 parts of chicory, 2 parts of gardenia jasminoides ellis, 2 parts of kudzu root and 3 parts of rhodiola rosea.
Rhodiola rosea (Sedum rosea) is a rhizome of rhodiola rosea Rholioa rosea limn. or rhodiola crenulata R.euryphylla (Frod.) S.H.Fu. of Crassulaceae. Has the effects of invigorating spleen, invigorating qi, clearing lung-heat, relieving cough, promoting blood circulation, and removing blood stasis. It is used for treating spleen qi deficiency syndrome, lung yin deficiency syndrome, and cough due to lung heat.
The following processing technology is preferred: soaking Cordyceps cicadae in old vinegar for 20-24 hr, drying, mixing with herba Dendrobii and fructus crataegi, pulverizing into coarse powder, treating with steam at 120 deg.C under 0.18-0.25 MPa for 4-8 s, adding distilled water and yeast, mixing to obtain wet residue, fermenting at 25-30 deg.C for 20-24 hr, and grinding into fine powder of 200 meshes or more with low temperature wall breaking machine; pulverizing other raw materials with a low-temperature wall breaking machine below-20 deg.C, adding water, heating, naturally cooling to 70-75 deg.C, maintaining the water evaporation to wet residue state, soaking in 95% ethanol for 1-1.5 hr, adding ultrasonic wave above 40KHz, shaking, recovering ethanol, mixing with Cordyceps cicadae flower, herba Dendrobii, and fructus crataegi, stirring, and making into beverage, tablet or instant granule with 3000-5000 MHZ microwave treatment.
The above process is the preferred method of processing through a number of experiments. Wherein, the cicada fungus is soaked in mature vinegar to dissolve out the effective components, which is convenient for human body to absorb and utilize. The coarse powder of dendrobium and hawthorn is subjected to steam pressurization and rapid treatment, so that disinfection and sterilization can be realized, decomposition and modification of effective components can be avoided, the effective components can be fully separated out through fermentation, and the coarse powder can be prepared into fine powder with super-strong permeability through low-temperature wall breaking, so that the effect time is greatly shortened. Other raw materials are subjected to low-temperature wall breaking and short-time high-temperature purification, effective components are still fully dissolved out even though the raw materials are not extracted after being soaked in ethanol, then the raw materials are further subjected to ultrasonic treatment for cracking and refining, and the raw materials are mixed and then subjected to microwave treatment, so that macromolecular groups can be further opened, particles are miniaturized, and the effect time of a patient after taking the composition is greatly shortened.
The results of the statistical comparison are shown in the following table:
in the table, data for this example formulation of experimental groups; control 1 is data of the second example experimental group; control 2 is data for the first example of chicory gardenia tea; control 3 is the data for the first embodiment of the western medicine. The data show that the effect of the rhodiola rosea is increased by being similar to that of the smilax glabra. Meanwhile, the effects of strengthening spleen and replenishing qi, clearing lung and relieving cough, and activating blood and dissolving stasis are enhanced, and the testee feels good.
Sixth embodiment: the eggplant stalk, the celery root, the bitter apricot seed and the honeysuckle are added on the basis of the first embodiment. Forming a new formula: 1-3 parts of hawthorn, 2-4 parts of dendrobium, 1-2 parts of cicada fungus, 3-7 parts of eggplant stalk, 3-5 parts of celery root, 2-4 parts of bitter almond and 1-3 parts of honeysuckle. The preferable raw materials comprise the following components in parts by weight: 2 parts of hawthorn, 2 parts of dendrobium, 2 parts of cicada fungus, 5 parts of eggplant stalk, 4 parts of celery root, 3 parts of bitter almond and 2 parts of honeysuckle.
Eggplant calyx, also called eggplant calyx and eggplant calyx, is the persistent calyx of green plant eggplant (scientific name: Solanum melongena L.) of Solanum of Solanaceae, can be eaten, is also a Chinese herbal medicine, has the effects of dissipating blood, promoting urination and dispelling toxicity, and is commonly used for treating intestinal wind and bleeding, carbuncle sore, aphtha and toothache.
Celery root is root of Otnanthe Ljavanica (B.) DC (scientific name: apex graveolens) or 0.5 times weight part of Parsley nudum (Latin name: Pternopetalum nudiflorum (de Boiss.) hand-d. -. Mazz. [ Cryptotaeniopsis nudiflorum de Boiss.) of Umbelliferae. Celery root has the functions of lowering blood pressure, lowering blood sugar, tranquilizing and allaying excitement. In addition, celery root can promote the metabolism and discharge of water, has the function of diuresis, and also contains cellulose, and has the functions of promoting digestion, expelling toxin, relaxing bowels and preventing intestinal cancer.
Bitter apricot seeds, also called almond, are used. Dried mature seeds of Prunus armeniaca L.var.ansu Maxim, Prunus sibirica L.of the Rosaceae family, Prunus armeniaca Koehne (Maxim.) mandshurica or Prunus armeniaca L.of the northeast China. Collecting mature fruits in summer, removing pulp and nucleocapsid, taking out seeds, and drying in the sun.
Honeysuckle flower, Lonicera japonica (Lonicera japonica), is a dried bud or flower with early blossoming flower of Lonicera of Caprifoliaceae and plants of the same genus. Good medicine for clearing heat and detoxicating. It is sweet and cold in nature and fragrant, sweet and cold in nature and clearing heat without hurting stomach, and the fragrance is thorough and can eliminate pathogens. It can disperse wind-heat and clear blood toxin, and has obvious effect on treating various heat diseases, such as fever, eruption, macula, sore and carbuncle due to heat toxin, sore throat, etc.
And the following processing technology is preferred: soaking Cordyceps cicadae in old vinegar for 20-24 hr, drying, mixing with herba Dendrobii and fructus crataegi, pulverizing into coarse powder, treating with steam at 120 deg.C under 0.18-0.25 MPa for 4-8 s, adding distilled water and yeast, mixing to obtain wet residue, fermenting at 25-30 deg.C for 20-24 hr, and grinding into fine powder of 200 meshes or more with low temperature wall breaking machine; pulverizing other raw materials with low temperature wall breaking machine, adding water to submerge the raw materials, heating to boil, stopping heating, naturally cooling to 70-75 deg.C, maintaining the water evaporation to wet residue state, soaking in 95% ethanol for 1-1.5 hr, adding 40KHz above ultrasonic wave, shaking, recovering ethanol, mixing with Cordyceps cicadae, herba Dendrobii, and fructus crataegi, stirring, and microwave treating at 3000-5000 MHZ to obtain beverage, tablet or instant granule.
The results of the statistical comparison are shown in the following table:
the experimental groups in the table are the formulation data of this example; control 1 is data of the second example experimental group; the data from the first example were used for the remaining two control groups. Therefore, the composition of the embodiment has little difference from the previous embodiment in the effect time, and the remission time is further shortened, which shows that the later effect is very good.
The seventh embodiment: because of shortage of cordyceps cicadae medicinal herbs, the cost is high. Therefore, a variety of substitutes have been found through extensive research. Wherein, various cordyceps cultivated artificially in various places at present can be used as a substitute raw material. This example only describes a scheme of using kelp and astragalus root instead of cordyceps sobolifera.
Laminaria japonica, Laminariaceae, is a plant of the family Zosteraceae, a large marine brown algae plant growing in seawater. The kelp has high nutritive value and certain medicinal value. The kelp is rich in mannitol, and is the main component of cordycepic acid contained in the cordyceps sobolifera.
Astragalus root, the Latin name Astragalus membranaceus (Fisch.) Bunge, Astragalus root, Du, Sichuan holly root, baiben, cotton bud, yellow ginseng and sang Shen. . Perennial herbaceous leguminous plants. Has the functions of enhancing the immunity of the organism,Health-care product Liver diseaseDiuresis, anti-aging, anti-stress, blood pressure lowering and wide antibacterial action. Can eliminate albuminuria caused by experimental nephritis, enhance myocardial contraction force, and regulateBlood sugarAnd (4) content. Radix astragali can not only dilate coronary artery, improve myocardial blood supply, and enhance immunity, but also delay cell aging process.
The following formula is formed:
A. 1-3 parts of hawthorn, 2-4 parts of dendrobium, 2-4 parts of silkworm chrysalis powder and kelp and 3-5 parts of astragalus membranaceus.
1-3 parts of hawthorn, 2-4 parts of dendrobium, 3-5 parts of kelp, 2-4 parts of astragalus membranaceus, 2-4 parts of chicory, 2-4 parts of gardenia jasminoides ellis and 1-3 parts of radix puerariae.
1-3 parts of hawthorn, 2-4 parts of dendrobium, 3-5 parts of kelp, 2-4 parts of astragalus, 2-4 parts of chicory, 2-4 parts of gardenia jasminoides ellis, 1-3 parts of kudzu root and 1-3 parts of glabrous greenbrier rhizome.
1-3 parts of hawthorn, 2-4 parts of dendrobium, 3-5 parts of kelp, 2-4 parts of astragalus, 2-4 parts of chicory, 2-4 parts of gardenia jasminoides ellis, 1-3 parts of kudzu root and 1-4 parts of rhodiola rosea.
1-3 parts of hawthorn, 2-4 parts of dendrobium, 3-5 parts of kelp, 2-4 parts of astragalus, 3-7 parts of eggplant stalk, 3-5 parts of celery root, 2-4 parts of bitter almond and 1-3 parts of honeysuckle.
Clinical experiments show that the curative effect statistics of the formula are as follows:
as can be seen from the table above, the kelp and astragalus membranaceus have the advantages of relatively similar curative effects to those of cordyceps cicadae, sufficient raw materials and low cost, have various tonifying efficacies on human bodies, and are a dietary therapy material with a great application prospect.
Claims (10)
1. An anti-uric acid functional food, which is characterized in that: the functional food comprises fructus crataegi, herba Dendrobii, and Cordyceps cicadae.
2. The anti-uric acid functional food according to claim 1, characterized in that: the functional food comprises the following raw materials in parts by weight: 1-3 parts of hawthorn, 2-4 parts of dendrobium nobile and 1-2 parts of cicada fungus.
3. The anti-uric acid functional food according to claim 2, characterized in that: the preparation method of the functional food comprises the following steps: the cordyceps cicadae is soaked in mature vinegar for 20-24 hours, dried, mixed with dendrobium and hawthorn and crushed into coarse powder, treated for 4-8 seconds under the pressure of 0.18-0.25 MPa of steam at 120 ℃, added with distilled water and yeast, mixed uniformly into a wet residue shape, fermented for 20-24 hours at 25-30 ℃, ground into fine powder with the granularity of more than 200 meshes by using a low-temperature wall breaking machine, and prepared into drinks or tablets or instant granules.
4. The anti-uric acid functional food according to claim 1, characterized in that: the Cordyceps cicadae is replaced by herba Zosterae Marinae and radix astragali.
5. The anti-uric acid functional food according to claim 4, characterized in that: 3-5 parts of kelp and 2-4 parts of astragalus.
6. The anti-uric acid functional food according to claim 2, characterized in that: 2-4 parts of chicory, 2-4 parts of gardenia jasminoides and 1-3 parts of kudzu root are added into the raw materials.
7. The anti-uric acid functional food according to claim 2, characterized in that: the raw materials are added with 2-4 parts of chicory, 2-4 parts of gardenia jasminoides, 1-3 parts of kudzu root and 1-3 parts of glabrous greenbrier rhizome.
8. The anti-uric acid functional food according to claim 2, characterized in that: the raw materials are added with 2-4 parts of chicory, 2-4 parts of gardenia jasminoides, 1-3 parts of kudzu root and 1-4 parts of rhodiola rosea.
9. The anti-uric acid functional food according to claim 2, characterized in that: 3-7 parts of eggplant stalk pedicel, 3-5 parts of celery root, 2-4 parts of bitter almond and 1-3 parts of honeysuckle are added into the raw materials.
10. The anti-uric acid functional food according to claim 6, 7, 8 or 9, characterized in that: the preparation method of the functional food comprises the following steps: soaking Cordyceps cicadae in old vinegar for 20-24 hr, drying, mixing with herba Dendrobii and fructus crataegi, pulverizing into coarse powder, treating with steam at 120 deg.C under 0.18-0.25 MPa for 4-8 s, adding distilled water and yeast, mixing to obtain wet residue, fermenting at 25-30 deg.C for 20-24 hr, and grinding into fine powder of 200 meshes or more with low temperature wall breaking machine; pulverizing other raw materials with low temperature wall breaking machine, adding water to submerge the raw materials, heating to boil, stopping heating, naturally cooling to 70-75 deg.C, maintaining the water evaporation to wet residue state, soaking in 95% ethanol for 1-1.5 hr, adding ultrasonic vibration, recovering ethanol, mixing the rest materials with Cordyceps cicadae, herba Dendrobii, and fructus crataegi, stirring, and processing with microwave processor to obtain beverage or tablet or instant granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110232538.5A CN113812613A (en) | 2021-03-03 | 2021-03-03 | Uric acid resistant functional food and preparation process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110232538.5A CN113812613A (en) | 2021-03-03 | 2021-03-03 | Uric acid resistant functional food and preparation process thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113812613A true CN113812613A (en) | 2021-12-21 |
Family
ID=78912467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110232538.5A Pending CN113812613A (en) | 2021-03-03 | 2021-03-03 | Uric acid resistant functional food and preparation process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113812613A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101647951A (en) * | 2009-09-10 | 2010-02-17 | 上海泛亚生命科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
| KR20130136151A (en) * | 2012-06-04 | 2013-12-12 | 권태선 | Improving gout, reducing uric acid, solving hangover of functional fermented food and method for producing of the same, and kimchi, gochujang, doenjang, soy sauce produced thereof |
| CN106138115A (en) * | 2016-07-19 | 2016-11-23 | 湖州新驰医药科技有限公司 | The new application of Chinese crude drug Cordyceps cicadae Shing |
| CN106924680A (en) * | 2015-12-29 | 2017-07-07 | 青岛智通四海家具设计研发有限公司 | Prevent and treat the composite superfine powder of hyperuricemia |
| CN106924645A (en) * | 2015-12-29 | 2017-07-07 | 青岛智通四海家具设计研发有限公司 | Alleviate gout and improve the Chinese medicine composition of hyperuricemia |
| CN106924571A (en) * | 2015-12-30 | 2017-07-07 | 张培君 | Chinese medicine composition for preventing and treating hyperuricemia |
| CN108653539A (en) * | 2018-07-19 | 2018-10-16 | 东莞市广易中医药发展有限公司 | A kind of reduction uric acid integration of drinking and medicinal herbs tabletting and preparation method thereof |
| CN108850366A (en) * | 2018-08-08 | 2018-11-23 | 广州宏韵医药科技股份有限公司 | A kind of alternative tea composition and preparation method thereof with anti-trioxypurine effect |
| CN109349384A (en) * | 2018-11-16 | 2019-02-19 | 万顺宝(肇庆)实业有限公司 | It is a kind of to have effects that reduce the miracle fruit compound tea and preparation method thereof of uric acid |
-
2021
- 2021-03-03 CN CN202110232538.5A patent/CN113812613A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101647951A (en) * | 2009-09-10 | 2010-02-17 | 上海泛亚生命科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
| KR20130136151A (en) * | 2012-06-04 | 2013-12-12 | 권태선 | Improving gout, reducing uric acid, solving hangover of functional fermented food and method for producing of the same, and kimchi, gochujang, doenjang, soy sauce produced thereof |
| CN106924680A (en) * | 2015-12-29 | 2017-07-07 | 青岛智通四海家具设计研发有限公司 | Prevent and treat the composite superfine powder of hyperuricemia |
| CN106924645A (en) * | 2015-12-29 | 2017-07-07 | 青岛智通四海家具设计研发有限公司 | Alleviate gout and improve the Chinese medicine composition of hyperuricemia |
| CN106924571A (en) * | 2015-12-30 | 2017-07-07 | 张培君 | Chinese medicine composition for preventing and treating hyperuricemia |
| CN106138115A (en) * | 2016-07-19 | 2016-11-23 | 湖州新驰医药科技有限公司 | The new application of Chinese crude drug Cordyceps cicadae Shing |
| CN108653539A (en) * | 2018-07-19 | 2018-10-16 | 东莞市广易中医药发展有限公司 | A kind of reduction uric acid integration of drinking and medicinal herbs tabletting and preparation method thereof |
| CN108850366A (en) * | 2018-08-08 | 2018-11-23 | 广州宏韵医药科技股份有限公司 | A kind of alternative tea composition and preparation method thereof with anti-trioxypurine effect |
| CN109349384A (en) * | 2018-11-16 | 2019-02-19 | 万顺宝(肇庆)实业有限公司 | It is a kind of to have effects that reduce the miracle fruit compound tea and preparation method thereof of uric acid |
Non-Patent Citations (1)
| Title |
|---|
| 马红珍: "《古今中医肾病辨治精要》", vol. 1, 人民军医出版社, pages: 349 - 353 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103719498B (en) | A kind of Siberian solomonseal rhizome health-care tea improving immunity and preparation method thereof | |
| CN105169118A (en) | Dendrobium officinale compound health buccal tablet and preparation method thereof | |
| CN106266898A (en) | A kind of vital energy benefiting and the kidney invigorating, the compound preparation and preparation method thereof of defying age | |
| CN112972586A (en) | Chinese herbal medicine composition preparation for treating hyperuricemia through fermentation of myxomycete and preparation method | |
| CN112057551A (en) | Composition with functions of nourishing yin and tonifying kidney and preparation method and application thereof | |
| CN102114102B (en) | Traditional Chinese medicine extract mixed preparation and application thereof | |
| CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
| CN103555530A (en) | Lily healthcare medicinal liquor | |
| CN104815192A (en) | Pharmaceutical composition for treating hypertension and application of pharmaceutical composition | |
| CN108210547B (en) | Preparation method of phyllanthus emblica leaf extract, preparation and anti-artemisia application thereof | |
| CN107114781B (en) | Health food for protecting liver and preparation method thereof | |
| CN107836620A (en) | A kind of health solid beverage and preparation method thereof | |
| CN111919982A (en) | Natural plant beverage for relieving alcoholism and preparation method thereof | |
| CN107812115A (en) | A kind of Chinese medicine composition for treating diabetes | |
| CN107753602A (en) | A kind of Chinese medicine composition for treating leukaemia and preparation method thereof | |
| CN109810824A (en) | A kind of dandelion wheat yellow wine yeast and preparation process | |
| CN113812613A (en) | Uric acid resistant functional food and preparation process thereof | |
| CN106072560A (en) | A kind of for health product treating gout and preparation method thereof | |
| CN102335276B (en) | Preparation method and application of tree peony extract and composition of tree peony extract | |
| CN102626471B (en) | Traditional Chinese medicine composition with effects of anti-anaphylaxis, desensitization, repair and regeneration | |
| CN105617268A (en) | Medicine for treating scale keratinization type beriberi | |
| KR101093006B1 (en) | Method for producing functional health food containing bezoar bovis used microbes and the functional health food produced by the same | |
| CN104840776A (en) | Traditional Chinese medicine for reducing blood pressure | |
| CN108721407A (en) | Two empty constitution conditioning lavipeditum powder of a kind of gas sun and preparation method thereof | |
| CN115531471B (en) | Composition for resisting African swine fever as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |